MOTC peptide (MOTS-c) is a mitochondrial-derived peptide studied for metabolism and insulin sensitivity. Learn what research shows, dosing, and FDA status.
MOTC peptide usually refers to MOTS-c, a 16-amino-acid mitochondrial-derived peptide that helps regulate metabolism, insulin sensitivity, and cellular stress responses. It was first described in 2015 and is encoded inside mitochondrial DNA rather than the nuclear genome, which makes it unusual among peptides. MOTS-c is a laboratory research compound — it is not FDA-approved for human use, and no clinical trial has proven it treats any medical condition.
What Is MOTS-c Peptide?
MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA type-c." The name describes where it comes from: a short open reading frame inside the 12S ribosomal RNA region of mitochondrial DNA.
People also write it as MOTC peptide, MOTS-C, or MOTS-c peptide. All of these refer to the same molecule. The basics:
- Size: 16 amino acids
- Origin: mitochondrial DNA, not nuclear DNA
- Class: mitochondrial-derived peptide (MDP)
- Status: research chemical; not approved as a drug in the US
There is no FDA-approved MOTS-c product for human use anywhere on the market.
How MOTS-c Works in the Body
MOTS-c acts like a metabolic signaling molecule. In cell and animal studies it activates AMPK, an enzyme often described as a cellular energy sensor.
Metabolic signaling
AMPK activation shifts cells toward burning fuel for energy and away from storing it. That is one reason researchers study MOTS-c in the context of obesity, type 2 diabetes, and exercise physiology.
Folate-methionine cycle
MOTS-c also regulates the folate-methionine cycle, which controls methylation reactions and antioxidant defenses. This links the peptide to aging research and to how cells manage oxidative stress.
Nuclear translocation
Under metabolic stress, MOTS-c moves from the mitochondria into the nucleus, where it influences expression of antioxidant and stress-response genes. This retrograde signaling is the peptide's most distinctive feature.
What Research Has Found So Far
Almost all published MOTS-c research comes from cells and rodents, not people. Human data is limited to observational studies and one discontinued drug program.
| Research area | Model | Reported finding |
|---|---|---|
| Insulin sensitivity | Mice | Treatment improved glucose handling and insulin response |
| Diet-induced obesity | Mice | Reduced weight gain and fat accumulation |
| Exercise capacity | Mice | Increased physical performance; proposed "exercise mimetic" effect |
| Bone and muscle | Mice and cells | Signals suggesting effects on bone mass and muscle metabolism |
| Circulating levels | Human observational | Levels decline with age and rise with exercise |
These findings are preliminary. Animal results frequently fail to translate into human benefits, and MOTS-c has not been tested in large randomized human trials.
One biotech company, CohBar, developed a MOTS-c analog called CB4211 and tested it in early human studies for fatty liver disease and obesity. The program was later discontinued, and the company wound down its operations in 2023. That history is the clearest signal of how difficult it is to turn MOTS-c into an approved drug.
MOTS-c Compared With Other Peptides
| Peptide | Main research focus | FDA-approved for humans? |
|---|---|---|
| MOTS-c | Metabolism, insulin sensitivity, aging | No |
| BPC-157 | Tissue repair and inflammation | No |
| PT-141 (bremelanotide) | Sexual desire | Yes, by prescription |
| AOD-9604 | Fat metabolism | No |
| Semaglutide (GLP-1) | Weight and blood sugar | Yes, by prescription |
MOTS-c is often confused with weight-loss drugs. It is not a GLP-1 receptor agonist, and it has nothing in common with a glucagon-like peptide-1 supplement.
Researchers who study metabolic peptides often compare MOTS-c with the aod9604 peptide, a fragment of human growth hormone that has been studied for fat metabolism. Other labs focus on repair and inflammation, such as the bpc-157 peptide for inflammation, or on entirely different pathways, like the pt141 peptide used in sexual medicine. MOTS-c belongs to the metabolic group, not the cosmetic or regenerative group.
Forms, Dosing, and What's Sold Online
MOTS-c is typically sold as a lyophilized powder in 10 mg vials and labeled "for research use only." Buyers usually see it as an injectable research peptide rather than a capsule, patch, or cream.
Rodent studies have used injected doses, but those numbers cannot be converted into human doses. There is no established human dosage, no human safety data at any dose, and no standard schedule.
Topical peptide products are a separate category entirely. A consumer product like the ordinary multi-peptide serum for hair density contains cosmetic peptides that sit on the skin surface, not mitochondrial signaling peptides. Comparing MOTS-c to a skincare serum means comparing two unrelated things.
Safety, Legality, and Risks
MOTS-c is not approved by the FDA for human use. In the United States, these peptides are sold legally only for laboratory research, not for human consumption.
- Unknown human safety profile
- No enforced manufacturing standards for most online vendors
- Risk of inaccurate dosing, contamination, or mislabeled vials
- Unknown interactions with diabetes or metabolic medications
Because MOTS-c influences glucose metabolism, anyone with diabetes or taking blood-sugar medication should be especially cautious. Speak with a licensed healthcare professional before using any unapproved peptide.
Bottom Line
MOTS-c is a genuinely interesting mitochondrial peptide with strong preclinical data, but the human evidence is thin. MOTS-c is not FDA-approved for human use in the United States, and no clinical trial has shown that it treats obesity, diabetes, or aging in people.
If you are considering it, treat marketing claims with skepticism and talk to a physician first. Evidence-based options exist for nearly every condition MOTS-c is promoted to address.
Frequently Asked Questions
Is MOTS-c peptide FDA-approved?
No. MOTS-c is not FDA-approved for human use in the United States. It is sold online as a research chemical and is not legally marketed as a drug, a supplement, or a treatment for any condition.
Is MOTC peptide the same as MOTS-c peptide?
Yes. "MOTC peptide" is a common shorthand and misspelling of MOTS-c, which stands for mitochondrial open reading frame of the 12S rRNA type-c. Both terms describe the same 16-amino-acid mitochondrial-derived peptide.
What does MOTS-c peptide do in the body?
In cell and animal studies, MOTS-c activates AMPK, regulates the folate-methionine cycle, and influences glucose metabolism and insulin sensitivity. It also moves into the nucleus under metabolic stress to affect antioxidant gene expression. Human effects remain unproven because no large clinical trial has been completed.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.